PLENDIL

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Ireland, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug PLENDIL contains one active pharmaceutical ingredient (API):

1 Felodipine UNII OL961R6O2C - FELODIPINE

Felodipine is a vascular selective calcium antagonist, which lowers arterial blood pressure by decreasing systemic vascular resistance. Felodipine is effective in all grades of hypertension. Read about Felodipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PLENDIL Prolonged-release tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA02	Felodipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2361G, 2366M, 2367N
Country: CA	Health Products and Food Branch	Identifier(s): 00851779, 00851787, 02057778
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28921-07-09, 28944-07-09
Country: EE	Ravimiamet	Identifier(s): 1019696, 1019708, 1028135, 1072482, 1072516, 1072527, 1732698, 1732700, 1732711, 1733790, 1733802, 1733813, 1733824, 1733835, 1733846, 1733914, 1733925, 1733936, 1733947, 1733992, 1734005, 1734016, 1734027, 1734038, 1734049
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59269
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 093062, 471441, 471466
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13551, 13552, 139461, 147217, 175887, 180654, 354774
Country: HK	Department of Health Drug Office	Identifier(s): 32695, 32696, 37191
Country: IE	Health Products Regulatory Authority	Identifier(s): 40030, 40031, 40035, 40041
Country: IT	Agenzia del Farmaco	Identifier(s): 028162030, 028162042
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003616, 1003731, 1019656, 1081017, 1081018, 1081019, 1081020, 1081021, 1081022, 1081023, 1081024, 1081025, 1081026, 1081027, 1081028, 1081029, 1081030, 1081031, 1081032, 1081033, 1081034, 1081035, 1081036, 1081037, 1081038, 1081039, 1081040, 1081041, 1081042, 1081043, 1081044, 1081045
Country: MT	Medicines Authority	Identifier(s): MA046/00201
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 224M89
Country: NG	Registered Drug Product Database	Identifier(s): 04-2256, 04-2257
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 35726
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4046, 4051, 4052
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100053594, 100053602
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W03102002, W03103001, W03104001
Country: SG	Health Sciences Authority	Identifier(s): 07738P, 08768P, 08781P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786030206, 8699786031340
Country: ZA	Health Products Regulatory Authority	Identifier(s): Y/7.1/294, Y/7.1/295